Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy
Authors:
- Falak SherFSFalak Sher
- Veerakumar BalasubramaniyanVBVeerakumar Balasubramaniyan
- Erik BoddekeEBErik Boddeke
- Sjef CopraySCSjef Copray
- 1 October 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 21 (5) , 607-614
Abstract
Recent research on oligodendrocyte development has yielded new insights on the involvement of morphogens and differentiation factors in oligodendrogenesis. This knowledge has improved strategies to control neural stem cell-derived oligodendrocyte differentiation and functional maturation in vitro. In this review, we highlight the current knowledge on oligodendrocyte differentiation and discuss the novel possibilities of neural stem cell-derived oligodendrocytes for graft-based remyelination therapy, for example, for multiple sclerosis. Detailed insight into the cellular and molecular processes of embryonic and adult oligodendrogenesis has extended considerably in the past 2 years. Application of extrinsic factors and manipulation of intrinsic factors in neural stem cells have yielded convincing oligodendrocyte differentiation strategies. In addition, the recent groundbreaking developments regarding induced pluripotent stem cells generated from easily accessible somatic cells seem to offer an almost inexhaustible source for transplantable, autologous neural stem cells. Moreover, new approaches to optimize the implantation site for oligodendrocyte survival and functionality have improved the feasibility of stem cell-based oligodendrocyte replacement therapy. Loss of myelin in demyelinating diseases is only partly restored by endogenous oligodendrocyte precursor cells. Application of optimally functional, neural stem cell-derived oligodendrocyte precursors at the lesion site has become a realistic therapeutic approach to promote the remyelination process.Keywords
This publication has 68 references indexed in Scilit:
- Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's diseaseProceedings of the National Academy of Sciences, 2008
- Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes to PluripotencyCell, 2008
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Musashi1 RNA‐binding protein regulates oligodendrocyte lineage cell differentiation and survivalGlia, 2007
- Post-Translational Modifications of Nucleosomal Histones in Oligodendrocyte Lineage Cells in Development and DiseaseJournal of Molecular Neuroscience, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- The Glial or Neuronal Fate Choice of Oligodendrocyte Progenitors Is Modulated by Their Ability to Acquire an Epigenetic MemoryJournal of Neuroscience, 2007
- The Transcription Factor Yin Yang 1 Is Essential for Oligodendrocyte Progenitor DifferentiationNeuron, 2007
- Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitorsProceedings of the National Academy of Sciences, 2007
- Specification of CNS glia from neural stem cells in the embryonic neuroepitheliumPhilosophical Transactions of the Royal Society B: Biological Sciences, 2007